Fig. 1.

KDM5A abundancy indicates unfavorable prognosis of PRAD patients. A mRNA expression of KDM5A in PRAD tumor tissues and the adjacent tissues evaluated by RT-qPCR (n = 60); B protein level of KDM5A in the PRAD tumor tissues and the adjacent tissues examined by IHC; C relevance of the KDM5A expression to the 5-year survival rate or PRAD patients. Data were collected from three independent experiments and expressed as mean ± SEM. Differences were analyzed by the paired t test (A and B), *p < 0.05, **p < 0.01. Survival rate of patients was analyzed by Log-rank test (C); #p < 0.05